GlobeNewswire
-
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
06/04/2026 -
Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026 -
GlucoZen Claim Evaluated: Highly-Effective Blood Sugar Support for Natural Glucose Harmony
06/04/2026 -
DIBS AI Unveils Version 9.0 Platform Suite to Streamline Orthodontic Workflows
06/04/2026 -
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
06/04/2026 -
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
06/04/2026 -
Sienna Senior Living recognized by The Globe and Mail’s Women Lead Here Benchmark
06/04/2026 -
Adaptin Bio Shares to be Quoted on the OTCQB Under Ticker Symbol APTN
06/04/2026 -
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure
06/04/2026 -
Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care
06/04/2026 -
Egg Medical Launches EggNest™ Complete Flex: Apron-Free Protection Without Construction, Downtime or Disruption
06/04/2026 -
Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
06/04/2026 -
Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026
06/04/2026 -
Egg Medical présente EggNest™ Complete Flex : une protection sans tablier, sans travaux, sans interruption de service ni perturbation
06/04/2026 -
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
06/04/2026 -
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026 -
Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team
06/04/2026 -
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
06/04/2026 -
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
06/04/2026
Pages